Browse diseases

…ere women (80/100) and 20% were men (20/100). The median age of migraine symptom onset was 18 years old, men had an older median age to …

…Introduction Migraine, a major headache disorder of high prevalence, affects approxim…

…, has emerged as a potential therapeutic strategy for improving migraine burden.Objective To evaluate the impact of bariatric surgery on…

…Objectives Migraine headaches are common and potentially disabling disorders, with several in…

…n); 28 (90.3%) had chronic and 3 (9.7%) high-frequency episodic migraine. Second-line treatment was erenumab in 30 patients (96.9%) and …

… Patients with fibromyalgia reported less numbness. Concomitant migraine was associated with more prevalent cyanosis, hyperaemia, RP pai…

…dizziness and encourages future studies of IV Mg for vestibular migraine. An assessment protocol for such a study is provided.kimberley.…

…existing market share of fremanezumab.Conclusion In people with migraine and MDD, fremanezumab treatment may result in substantial total…

… vs 69.9%) and SARD-RP (84.1% and 70.9%, respectively). In PRP, migraine was associated with higher prevalence of cyanosis (50.0% vs 44.…

…uded, 80.4% female, with a mean age of 44.0±13.8 years. Chronic migraine was present in 23.9% and high-frequency episodic migraine (HFEM…

…ly approved oral calcitonin gene-related peptide antagonist for migraine prophylaxis in adults. Real-world data on its efficacy and safe…

…clusion and Relevance Oral CGRP antagonists effectively reduced migraine frequency and improved quality of life in real-world settings. …